Fasting hyperglycaemia and fatty liver drive colorectal cancer: a retrospective analysis in 1145 patients
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Fasting hyperglycaemia and fatty liver drive colorectal cancer: a retrospective analysis in 1145 patients ; day:26 ; month:4 ; year:2024 ; pages:1-11
Internal and emergency medicine ; (26.4.2024), 1-11
- Creator
-
Crudele, Lucilla
De Matteis, Carlo
Novielli, Fabio
Petruzzelli, Stefano
Di Buduo, Ersilia
Graziano, Giusi
Cariello, Marica
Piccinin, Elena
Gadaleta, Raffaella Maria
Moschetta, Antonio
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s11739-024-03596-6
- URN
-
urn:nbn:de:101:1-2407092120428.088575916086
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Crudele, Lucilla
- De Matteis, Carlo
- Novielli, Fabio
- Petruzzelli, Stefano
- Di Buduo, Ersilia
- Graziano, Giusi
- Cariello, Marica
- Piccinin, Elena
- Gadaleta, Raffaella Maria
- Moschetta, Antonio
- SpringerLink (Online service)
Other Objects (12)
Incidence and risk factors of fasting hyperglycaemia following first-attack acute pancreatitis before discharge: a retrospective study
Fatty acids homeostasis during fasting predicts protection from chemotherapy toxicity
Prevalence of postprandial hyperglycaemia in basal insulin-treated patients with type 2 diabetes mellitus with controlled fasting glycaemia and elevated glycosylated haemoglobin
1145
1145
1145
Fasting-mimicking diet remodels gut microbiota and suppresses colorectal cancer progression
Beneficial effects of intermittent fasting on nonalcoholic fatty liver disease: a narrative review
Practical Guide to Glucocorticoid Induced Hyperglycaemia and Diabetes
Hyperglycaemia on admission to hospital and COVID-19
Emerging concepts in metformin therapy: Hyperglycaemia and beyond
Discriminatory ability of anthropometric measurements of central fat distribution for prediction of post-prandial hyperglycaemia in patients with normal fasting glucose: the DICAMANO Study
Incidence and risk factors of fasting hyperglycaemia following first-attack acute pancreatitis before discharge: a retrospective study
Fatty acids homeostasis during fasting predicts protection from chemotherapy toxicity
Prevalence of postprandial hyperglycaemia in basal insulin-treated patients with type 2 diabetes mellitus with controlled fasting glycaemia and elevated glycosylated haemoglobin
1145
1145
1145
Fasting-mimicking diet remodels gut microbiota and suppresses colorectal cancer progression
Beneficial effects of intermittent fasting on nonalcoholic fatty liver disease: a narrative review
Practical Guide to Glucocorticoid Induced Hyperglycaemia and Diabetes
Hyperglycaemia on admission to hospital and COVID-19
Emerging concepts in metformin therapy: Hyperglycaemia and beyond
Discriminatory ability of anthropometric measurements of central fat distribution for prediction of post-prandial hyperglycaemia in patients with normal fasting glucose: the DICAMANO Study
Incidence and risk factors of fasting hyperglycaemia following first-attack acute pancreatitis before discharge: a retrospective study
Fatty acids homeostasis during fasting predicts protection from chemotherapy toxicity
Prevalence of postprandial hyperglycaemia in basal insulin-treated patients with type 2 diabetes mellitus with controlled fasting glycaemia and elevated glycosylated haemoglobin
1145
1145
1145
Fasting-mimicking diet remodels gut microbiota and suppresses colorectal cancer progression
Beneficial effects of intermittent fasting on nonalcoholic fatty liver disease: a narrative review
Practical Guide to Glucocorticoid Induced Hyperglycaemia and Diabetes
Hyperglycaemia on admission to hospital and COVID-19
Emerging concepts in metformin therapy: Hyperglycaemia and beyond